Sep 18, 2023 / 10:00AM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
We're ready to go. So good morning, everybody. I'm Chris Schott, the pharma analyst here at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Pfizer. From the company, we have Dave Denton, the company's CFO, and before we jump into, which will be, I'm sure, a very interesting discussion. We have Ronen, from the IR team, read disclosure here, and then we'll dive into the conversation from there.
Ronen Tamir - Pfizer Inc. - VP of IR
Thank you, Chris. I just wanted to inform you that we are going to be making some forward-looking statements. And then we're going to be making those looking forward statements that are true for today. And if you have any additional questions, on the forward-looking statements, please see the relevant sectors in our SEC filing on the Forms 10-Q and 10-K. Thank you.
Pfizer Inc at JPMorgan U.S. All Stars Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers